214 related articles for article (PubMed ID: 30065049)
1. Canonical Wnt Signaling Remodels Lipid Metabolism in Zebrafish Hepatocytes following Ras Oncogenic Insult.
Yao Y; Sun S; Wang J; Fei F; Dong Z; Ke AW; He R; Wang L; Zhang L; Ji MB; Li Q; Yu M; Shi GM; Fan J; Gong Z; Wang X
Cancer Res; 2018 Oct; 78(19):5548-5560. PubMed ID: 30065049
[TBL] [Abstract][Full Text] [Related]
2. A high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafish.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Lam SH; Mathavan S; Parinov S; Gong Z
Dis Model Mech; 2011 Nov; 4(6):801-13. PubMed ID: 21729876
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analyses of oncogenic hepatocytes reveal common and different molecular pathways of hepatocarcinogenesis in different developmental stages and genders in kras
Huo X; Li H; Li Z; Yan C; Mathavan S; Liu J; Gong Z
Biochem Biophys Res Commun; 2019 Mar; 510(4):558-564. PubMed ID: 30739784
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRAS promotes malignant brain tumors in zebrafish.
Ju B; Chen W; Orr BA; Spitsbergen JM; Jia S; Eden CJ; Henson HE; Taylor MR
Mol Cancer; 2015 Feb; 14(1):18. PubMed ID: 25644510
[TBL] [Abstract][Full Text] [Related]
5. An inducible kras(V12) transgenic zebrafish model for liver tumorigenesis and chemical drug screening.
Nguyen AT; Emelyanov A; Koh CH; Spitsbergen JM; Parinov S; Gong Z
Dis Model Mech; 2012 Jan; 5(1):63-72. PubMed ID: 21903676
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.
Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC
Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423
[TBL] [Abstract][Full Text] [Related]
7. Development of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish.
Nguyen AT; Koh V; Spitsbergen JM; Gong Z
Sci Rep; 2016 Jan; 6():19559. PubMed ID: 26790949
[TBL] [Abstract][Full Text] [Related]
8. Chemical inhibition reveals differential requirements of signaling pathways in kras
Yan C; Yang Q; Huo X; Li H; Zhou L; Gong Z
Sci Rep; 2017 Apr; 7():45796. PubMed ID: 28378824
[TBL] [Abstract][Full Text] [Related]
9. Diet-induced hepatic steatosis activates Ras to promote hepatocarcinogenesis via CPT1α.
Xu A; Wang B; Fu J; Qin W; Yu T; Yang Z; Lu Q; Chen J; Chen Y; Wang H
Cancer Lett; 2019 Feb; 442():40-52. PubMed ID: 30401637
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish.
Yan C; Huo X; Wang S; Feng Y; Gong Z
J Hepatol; 2015 Aug; 63(2):420-8. PubMed ID: 25828472
[TBL] [Abstract][Full Text] [Related]
11. Inducible Intestine-Specific Expression of kras
Lu JW; Raghuram D; Fong PA; Gong Z
Neoplasia; 2018 Dec; 20(12):1187-1197. PubMed ID: 30390498
[TBL] [Abstract][Full Text] [Related]
12. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
13. CTGF Mediates Tumor-Stroma Interactions between Hepatoma Cells and Hepatic Stellate Cells to Accelerate HCC Progression.
Makino Y; Hikita H; Kodama T; Shigekawa M; Yamada R; Sakamori R; Eguchi H; Morii E; Yokoi H; Mukoyama M; Hiroshi S; Tatsumi T; Takehara T
Cancer Res; 2018 Sep; 78(17):4902-4914. PubMed ID: 29967264
[TBL] [Abstract][Full Text] [Related]
14. RASSF1A Deficiency Enhances RAS-Driven Lung Tumorigenesis.
Schmidt ML; Hobbing KR; Donninger H; Clark GJ
Cancer Res; 2018 May; 78(10):2614-2623. PubMed ID: 29735543
[TBL] [Abstract][Full Text] [Related]
15. Long-Chain n-3 Fatty Acids Attenuate Oncogenic KRas-Driven Proliferation by Altering Plasma Membrane Nanoscale Proteolipid Composition.
Fuentes NR; Mlih M; Barhoumi R; Fan YY; Hardin P; Steele TJ; Behmer S; Prior IA; Karpac J; Chapkin RS
Cancer Res; 2018 Jul; 78(14):3899-3912. PubMed ID: 29769200
[TBL] [Abstract][Full Text] [Related]
16. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
[TBL] [Abstract][Full Text] [Related]
17. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
[TBL] [Abstract][Full Text] [Related]
18. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
19. Peroxiredoxin I is important for cancer-cell survival in Ras-induced hepatic tumorigenesis.
Han B; Shin HJ; Bak IS; Bak Y; Jeong YL; Kwon T; Park YH; Sun HN; Kim CH; Yu DY
Oncotarget; 2016 Oct; 7(42):68044-68056. PubMed ID: 27517622
[TBL] [Abstract][Full Text] [Related]
20. Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish.
Yang Q; Yan C; Gong Z
Sci Rep; 2018 May; 8(1):8495. PubMed ID: 29855567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
